Resources Library by ANA

Transfer of business intelligence requires further specialisation

Agencies specialising in pharmaceutical market research are operating in an increasingly complex market, a trend which is expected to continue as the healthcare environment evolves. The purpose of this paper is to bring forward the hypothesis that to...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Christian Savelkouls, Craig Granowitz

June 1, 1995

The detailed evaluation and analysis of the cardiovascular market in Russia

The paper reports the results of a detailed study of the cardiovascular marketplace in Russia. This was a diary study executed among 97 generalists and 50 specialists working in polyclinics across Russia. The study covered all aspects of 2,367...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Marianne Fletcher, Natasha Retejum, Stephen Godwin

Company: KANTAR TNS Malaysia

June 1, 1995

Competitive intelligence

This paper has indicated that Competitive Intelligence represents the flip-side of the strategy coin. Strategy without intelligence, we have suggested, is not strategy, it is guessing. Some pharmaceutical firms are making considerable progress toward...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: Douglas C. Bernhardt

June 1, 1995

Consumers’ attitude towards instructions

This paper will mainly show the actual interest patients feel towards the instructions but also the difficulties they face in trying to understand them accurately and will suggest ways to eliminate these problems. At the suggestion of the Austrian...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: Lisl Putschi

Company: GfK

June 1, 1995

Forecasting pharmaceutical brands

The aim of this paper is to examine how pharmaceutical forecasting is currently conducted, from different clients' perspectives, to stimulate discussion and to make recommendations about how the practice could be improved. Pharmaceutical forecasting,...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Oliver Mast, Sandra Buckeldee

June 1, 1995

Good quality for better quantity

Structured and systematic monitoring of the competition is increasingly becoming a key means of assuring a company's success. While the collection and processing of relevant data is still relatively easy, analysis and interpretation of relevant...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: Holger Paulsen

June 1, 1995

The 'heavyweights'

I plan to share with you some innovative market research completed to help us estimate the dollar potential for a prescription "weight loss" product in Europe using only medical promotional efforts. Our hypothesis was that even though we did not...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Author: William V. Lawson

June 1, 1995

Evaluating and forecasting prescribing

The paper is divided into four main sections. The Methodology describes the data upon which the analyses were based and explains the theoretical background to the approach adopted. The Results are then presented to show how large and small drugs...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Andrew S. C. Ehrenberg, Philip Stern

June 1, 1995

Through the looking glass

The paper describes a case study carried out in 1994 to examine the potential for a number of new possible line extensions (formulations) of an existing product. Management required an extremely accurate forecast of the likely impact of the new forms...

Catalogue: EphMRA/ESOMAR Conference 1995: Pharmaceutical Marketing Research- The Challenge For Growth

Authors: Raf De Wilde, Alan J. Bowditch, Simon Fitall

June 1, 1995